Almitas Capital »

Spruce Biosciences shares owned by Almitas Capital

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Almitas Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $205k 397k 0.52

More positions owned by Almitas Capital

BlackRock Health Sciences Term Trust Com Shs (BMEZ)
Nuveen Core Plus Impact Fund Com Ben Int (NPCT)
BlackRock ESG Capital Allocation Term Trust Shs Ben Int (ECAT)
Nuveen PA Investnt Quality Municipal (NQP)
Miller/Howard High Dividend Fund Com Shs Ben In (HIE)
Nuveen Preferred And equity (JPI)
Mainstay Definedterm Mn Opp (MMD)
Pgim Short Dur Hig Yld Opp F (SDHY)
Tortoise Midstream Energy M (NTG)
Eaton Vance New York Municipal Bond Fund (ENX)
Bny Mellon Mun Income (DMF)
New America High Income Fund Inc/The Com New (HYB)
Atea Pharmaceuticals (AVIR)
Tortoise Pipeline & Energy F (TTP)
Design Therapeutics (DSGN)

View all positions for Almitas Capital

Top funds holding Spruce Biosciences

RiverVest Venture Management
Carlyle
Rock Springs Capital Management
Acadian Asset Management
Vanguard Group
Altium Capital Management
Almitas Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
683 Capital Management
BlackRock
Bridgeway Capital Management
Superstring Capital Management
Lion Point Capital

View all funds holding Spruce Biosciences